Insider · CIK 0002001571
Carole Huntsman
officer
Files at MDGL (MADRIGAL PHARMACEUTICALS, INC.). First filing Nov 22, 2024, latest Nov 21, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $2.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDGL: MADRIGAL PHARMACEUTICALS, INC.
MDGLOct 9, 2026 · close 471.75
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | MADRIGAL PHARMACEUTICALS, INC. | $1.1M 1,958 shares | -16% | +105% from low-2% from high | |
| 34Weak | MADRIGAL PHARMACEUTICALS, INC. | $598k 1,834 shares | -18% | - | |
| 33Weak | MADRIGAL PHARMACEUTICALS, INC. | $116k 347 shares | -3% | - | |
| 42Moderate | MADRIGAL PHARMACEUTICALS, INC. | $218k 688 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -894 | $550.97 | $493k | 11,096 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -144 | $547.27 | $79k | 10,952 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -120 | $548.71 | $66k | 10,832 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -40 | $549.34 | $22k | 10,792 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $552.38 | $110k | 10,592 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -40 | $553.23 | $22k | 10,552 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -120 | $556.04 | $67k | 10,432 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $559.60 | $112k | 10,232 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -80 | $560.62 | $45k | 10,152 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -40 | $563.21 | $23k | 10,112 | Nov 21, 2025 |
| Nov 21, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -80 | $564.57 | $45k | 10,032 | Nov 21, 2025 |
| Mar 5, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +3,386 | $0.00 | $0 | 11,990 | Mar 7, 2025 |
| Mar 5, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +5,703 | $0.00 | $0 | 5,703 | Mar 7, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -71 | $313.08 | $22k | 10,367 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $314.74 | $63k | 10,167 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -300 | $320.21 | $96k | 9,867 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $323.65 | $65k | 9,667 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $324.59 | $65k | 9,467 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $326.34 | $33k | 9,367 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $327.49 | $33k | 9,267 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $329.64 | $33k | 9,167 | Mar 5, 2025 |
| Mar 3, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -563 | $335.00 | $189k | 8,604 | Mar 5, 2025 |
| Jan 24, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -347 | $335.24 | $116k | 10,438 | Jan 27, 2025 |
| Nov 21, 2024 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -688 | $316.92 | $218k | 10,785 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.